2024–2025
Zürich says puberty blockers stay available with specialist assessment.
What the law allows
Medical care for minorsAffirming
NEK-CNE opinion 43/2024 describes puberty blockade as current practice; Zurich’s health directorate said access to puberty blockers is not being restricted.
NEK-CNE — Opinion 43/2024 (EN)
Key dates2024–2025
2024–2025: NEK-CNE opinion 43/2024 describes puberty blockade as current practice; Zurich’s health directorate said access to puberty blockers is not being restricted.
NEK-CNE — Opinion 43/2024 (EN)
Official sources
Europe. Zürich says puberty blockers remain unrestricted.
Full official record
The National Advisory Commission on Biomedical Ethics 2024 opinion addresses medical treatment of minors with gender dysphoria, including puberty blockers after Tanner 2 under specialist care. Canton Zürich’s Health Directorate stated on 11 July 2025 that access to puberty blockers for transgender adolescents remains unrestricted, prescribed by specialist endocrinologists after interdisciplinary assessment.